MCID: NNS011
MIFTS: 35

Nonseminomatous Germ Cell Tumor

Categories: Rare diseases

Aliases & Classifications for Nonseminomatous Germ Cell Tumor

MalaCards integrated aliases for Nonseminomatous Germ Cell Tumor:

Name: Nonseminomatous Germ Cell Tumor 49 69
Non-Seminomatous Germ-Cell Tumors 49
Nsgct 49

Classifications:



External Ids:

UMLS 69 C1266158

Summaries for Nonseminomatous Germ Cell Tumor

NIH Rare Diseases : 49 Nonseminomatous germ celltumors are cancerous tumors commonly found in the pineal gland in the brain, in the mediastinum, or in the abdomen. They originate from cells that were meant to form sex cells (i.e., sperm or eggs). They are often large and have a tendency to spread more quickly than the other type of germ cell tumor (i.e., seminoma type). Possible early signs of this cancer include chest pain and breathing problems. Last updated: 10/17/2013

MalaCards based summary : Nonseminomatous Germ Cell Tumor, also known as non-seminomatous germ-cell tumors, is related to choriocarcinoma and testicular cancer. An important gene associated with Nonseminomatous Germ Cell Tumor is AFP (Alpha Fetoprotein), and among its related pathways/superpathways is Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors. The drugs Dexamethasone and Paclitaxel have been mentioned in the context of this disorder. Affiliated tissues include testis, brain and pineal, and related phenotypes are Decreased shRNA abundance (Z-score < -2) and Decreased shRNA abundance (Z-score < -2)

Related Diseases for Nonseminomatous Germ Cell Tumor

Graphical network of the top 20 diseases related to Nonseminomatous Germ Cell Tumor:



Diseases related to Nonseminomatous Germ Cell Tumor

Symptoms & Phenotypes for Nonseminomatous Germ Cell Tumor

GenomeRNAi Phenotypes related to Nonseminomatous Germ Cell Tumor according to GeneCards Suite gene sharing:

25 (show all 14)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased shRNA abundance (Z-score < -2) GR00366-A-134 10.26 CGB7 CGB5
2 Decreased shRNA abundance (Z-score < -2) GR00366-A-160 10.26 CGB5 CGB7
3 Decreased shRNA abundance (Z-score < -2) GR00366-A-179 10.26 CGB5 CGB7
4 Decreased shRNA abundance (Z-score < -2) GR00366-A-59 10.26 CGB5 CGB7
5 Decreased shRNA abundance (Z-score < -2) GR00366-A-95 10.26 CGB7 CGB5
6 Increased shRNA abundance (Z-score > 2) GR00366-A-118 9.6 CGB7 CGB5
7 Increased shRNA abundance (Z-score > 2) GR00366-A-161 9.6 ERBB2
8 Increased shRNA abundance (Z-score > 2) GR00366-A-163 9.6 ERBB2
9 Increased shRNA abundance (Z-score > 2) GR00366-A-168 9.6 ERBB2
10 Increased shRNA abundance (Z-score > 2) GR00366-A-207 9.6 ERBB2
11 Increased shRNA abundance (Z-score > 2) GR00366-A-32 9.6 ERBB2 CGB7 CGB5
12 Increased shRNA abundance (Z-score > 2) GR00366-A-42 9.6 CGB7 CGB5
13 Increased shRNA abundance (Z-score > 2) GR00366-A-63 9.6 ERBB2
14 Increased shRNA abundance (Z-score > 2) GR00366-A-85 9.6 ERBB2

Drugs & Therapeutics for Nonseminomatous Germ Cell Tumor

Drugs for Nonseminomatous Germ Cell Tumor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 104)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 50-02-2 5743
2
Paclitaxel Approved, Vet_approved Phase 3,Phase 2,Phase 1 33069-62-4 36314
3
Etoposide Approved Phase 3,Phase 2 33419-42-0 36462
4
Cisplatin Approved Phase 3,Phase 2,Phase 1 15663-27-1 2767 441203 84093
5
Carboplatin Approved Phase 3,Phase 2,Phase 1 41575-94-4 10339178 38904 498142
6
Bleomycin Approved, Investigational Phase 3,Phase 2 11056-06-7 5360373
7
Ifosfamide Approved Phase 3,Phase 2,Phase 1 3778-73-2 3690
8
Mechlorethamine Approved, Investigational Phase 3,Phase 2,Phase 1 51-75-2 4033
9
Oxaliplatin Approved, Investigational Phase 3,Phase 2 61825-94-3 43805 6857599 5310940 9887054
10
Mesna Approved, Investigational Phase 3,Phase 1,Phase 2 3375-50-6 598
11
Lenograstim Approved, Investigational Phase 2, Phase 3, Phase 1 135968-09-1
12
Diphenhydramine Approved, Investigational Phase 3 58-73-1, 147-24-0 3100
13
Promethazine Approved, Investigational Phase 3 60-87-7 4927
14
Vinblastine Approved Phase 3 865-21-4 241903 13342
15
Histamine Approved, Investigational Phase 3 51-45-6, 75614-87-8 774
16
Cyproheptadine Approved Phase 3 129-03-3 2913
17 Dexamethasone acetate Phase 3,Phase 2,Phase 1 1177-87-3
18 Isophosphamide mustard Phase 3,Phase 2,Phase 1 0
19 Alkylating Agents Phase 3,Phase 2,Phase 1
20 Adjuvants, Immunologic Phase 3,Phase 1,Phase 2
21 Albumin-Bound Paclitaxel Phase 3,Phase 2,Phase 1
22 Gastrointestinal Agents Phase 3,Phase 2
23 Topoisomerase Inhibitors Phase 3,Phase 2
24 Anti-Bacterial Agents Phase 3,Phase 2
25 Etoposide phosphate Phase 3,Phase 2
26 Antimitotic Agents Phase 3,Phase 2,Phase 1
27 Antibiotics, Antitubercular Phase 3,Phase 2
28 Antineoplastic Agents, Phytogenic Phase 3,Phase 2,Phase 1
29 BB 1101 Phase 3,Phase 2,Phase 1
30 Histamine H2 Antagonists Phase 3
31
Histamine Phosphate Phase 3 51-74-1 65513
32
Serotonin Phase 3 50-67-9 5202
33 Serotonin Agents Phase 3
34 Serotonin Antagonists Phase 3
35 Neurotransmitter Agents Phase 3
36 Histamine Antagonists Phase 3
37 Histamine H1 Antagonists Phase 3
38 Dermatologic Agents Phase 3
39 Anti-Allergic Agents Phase 3
40 Antipruritics Phase 3
41
Mannitol Approved, Investigational Phase 1, Phase 2 69-65-8 6251 453
42
Gemcitabine Approved Phase 2,Phase 1 95058-81-4 60750
43
Furosemide Approved, Vet_approved Phase 1, Phase 2 54-31-9 3440
44
Ranitidine Approved Phase 1, Phase 2 66357-59-3, 66357-35-5 3001055
45
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 1, Phase 2 7487-88-9 24083
46
Vincristine Approved, Investigational Phase 2 2068-78-2, 57-22-7 5978
47
Sunitinib Approved, Investigational Phase 2 341031-54-7, 557795-19-4 5329102
48
Fluorouracil Approved Phase 2 51-21-8 3385
49
Levoleucovorin Approved, Investigational Phase 2 68538-85-2
50
Melphalan Approved Phase 2 148-82-3 460612 4053

Interventional clinical trials:

(show all 37)

# Name Status NCT ID Phase Drugs
1 Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors Unknown status NCT00104676 Phase 3 cisplatin;etoposide;ifosfamide;oxaliplatin;paclitaxel
2 Combination Chemotherapy in Treating Men With Germ Cell Cancer Unknown status NCT00003643 Phase 2, Phase 3 cisplatin;etoposide;paclitaxel
3 Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors Recruiting NCT02375204 Phase 3 paclitaxel;ifosfamide;cisplatin;pegylated G-CSF;G-CSF;carboplatin;etoposide phosphate
4 Trial of 1 Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Testis Tumours Active, not recruiting NCT01726374 Phase 3 BEP(500)
5 Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer Terminated NCT01132547 Phase 3 cyproheptadine hydrochloride
6 Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors Terminated NCT00072215 Phase 3 cisplatin;ifosfamide;paclitaxel;vinblastine
7 Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors Unknown status NCT00127049 Phase 2 gemcitabine, ifosfamide, cisplatin, G-CSF
8 High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy Unknown status NCT01172912 Phase 2 carboplatin;cisplatin;dexamethasone;etoposide;ifosfamide
9 Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors Unknown status NCT00551122 Phase 1, Phase 2 cisplatin;gemcitabine hydrochloride;ifosfamide;paclitaxel
10 High-dose Chemotherapy With Autologous Stem Cell Rescue in Pediatric High-risk Brain Tumors Completed NCT00798811 Phase 2
11 Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors Completed NCT00957905 Phase 2 Alvocidib Hydrochloride;Fluorouracil;Leucovorin Calcium;Oxaliplatin
12 Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors Completed NCT00301782 Phase 2 carboplatin;cisplatin;etoposide phosphate;vincristine sulfate
13 Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors Completed NCT00470366 Phase 2 cisplatin;ifosfamide;paclitaxel
14 Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin Completed NCT00423852 Phase 1, Phase 2 carboplatin;ifosfamide;paclitaxel
15 Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment Completed NCT00453310 Phase 2 sunitinib malate
16 Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors Completed NCT00453232 Phase 2 cisplatin;etoposide
17 Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors Completed NCT00070096 Phase 2 ixabepilone
18 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer Completed NCT00002931 Phase 2 carboplatin;etoposide;ifosfamide;paclitaxel
19 A Prospective Study of Cabazitaxel in Patients With Non Seminomatous Germ-cell Tumors Recruiting NCT02115165 Phase 2 Cabazitaxel
20 Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor Recruiting NCT02784054 Phase 2 Carboplatin;Etoposide;Cyclophosphamide;Bleomycin;Thiotepa;Melphalan
21 First Line TIP in Poor Prognosis TGCTs. Recruiting NCT02414685 Phase 2 Paclitaxel;Ifosfamide;Cisplatin
22 Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors Recruiting NCT02689219 Phase 2 Brentuximab Vedotin
23 Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy Recruiting NCT02317393 Phase 2
24 Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers Recruiting NCT02034110 Phase 2 Dabrafenib;Trametinib
25 PHASE II TRIAL OF THE CYCLIN-DEPEDENT KINASE INHIBITOR PD 0332991 IN PATIENTS WITH CANCER Recruiting NCT01037790 Phase 2 PD-0332991
26 Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors Recruiting NCT03158064 Phase 2 Durvalumab;Tremelimumab
27 Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors Recruiting NCT00432094 Phase 2 carboplatin;etoposide;ifosfamide;paclitaxel;thiotepa;Mesna
28 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Recruiting NCT02834013 Phase 2
29 Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors Terminated NCT02499952 Phase 2 Pembrolizumab
30 Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors Terminated NCT01808534 Phase 2 palifosfamide
31 Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors Completed NCT00313599 Phase 1 lapatinib;paclitaxel
32 Follow-up Evaluation Using CT Scans in Patients Who Have Been Treated For Metastatic Testicular Cancer Unknown status NCT00553371
33 Positron Emission Tomography in Detecting Testicle Cancer Completed NCT00045045
34 Diagnostic Study of Patients With Stage I Testicular Cancer Completed NCT00003800
35 Swiss Austrian German Testicular Cancer Cohort Study - SAG TCCS Recruiting NCT02229916
36 Proton Beam Radiation Therapy for Central Nervous System (CNS) Germ Cell Tumors Active, not recruiting NCT01049230
37 Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor Active, not recruiting NCT00638898 busulfan;melphalan;topotecan hydrochloride

Search NIH Clinical Center for Nonseminomatous Germ Cell Tumor

Genetic Tests for Nonseminomatous Germ Cell Tumor

Anatomical Context for Nonseminomatous Germ Cell Tumor

MalaCards organs/tissues related to Nonseminomatous Germ Cell Tumor:

38
Testis, Brain, Pineal, Lymph Node, Bone, Testes, Prostate

Publications for Nonseminomatous Germ Cell Tumor

Articles related to Nonseminomatous Germ Cell Tumor:

(show top 50) (show all 151)
# Title Authors Year
1
Durable Response to Immune Checkpoint Blockade in a Platinum-Refractory Patient With Nonseminomatous Germ Cell Tumor. ( 28465048 )
2017
2
Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis. ( 27861143 )
2016
3
Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients. ( 27533924 )
2016
4
High-Dose Chemotherapy in a Late Relapse, Platinum-Refractory Nonseminomatous Germ Cell Tumor. ( 27055370 )
2016
5
Defining a New Prognostic Index for Stage I Nonseminomatous Germ Cell Tumors Using CXCL12 Expression and Proportion of Embryonal Carcinoma. ( 26453693 )
2016
6
Perioperative Morbidity and Mortality Associated With Bleomycin in Primary Mediastinal Nonseminomatous Germ Cell Tumor. ( 27621392 )
2016
7
Primary nonseminomatous germ cell tumor in the posterior mediastinum. ( 25473562 )
2014
8
Long term outcome of patients with clinical stage I high-risk nonseminomatous germ cell tumors 15 years after one adjuvant cycle of Bleomycin, Etoposide and Cisplatin chemotherapy. ( 25392157 )
2014
9
Post-chemotherapy laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors infiltrating the great vessels. ( 24422683 )
2014
10
Growing Teratoma Syndrome After Treatment of a Nonseminomatous Germ Cell Tumor: A Case Report and a Review of Literature. ( 26952048 )
2014
11
Prognostic factors and efficacy of different chemotherapeutic regimens in patients with mediastinal nonseminomatous germ cell tumors. ( 24337455 )
2014
12
Anatomical retroperitoneoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors: Initial operative experience. ( 24369147 )
2014
13
Re: genomic characterization of testis cancer: association of alterations with outcome of clinical stage 1 mixed germ cell nonseminomatous germ cell tumor of the testis. ( 23845335 )
2013
14
Salvage therapy with high-dose chemotherapy and peripheral blood stem cell transplant in patients with primary mediastinal nonseminomatous germ cell tumors. ( 22892555 )
2013
15
Nonseminomatous germ cell tumor of testis and interrupted treatment. ( 24133836 )
2013
16
Risk factors for relapse in patients with clinical stage I testicular nonseminomatous germ cell tumors. ( 23400963 )
2013
17
Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients. ( 23021090 )
2013
18
Testicular hilum and vascular invasion predict advanced clinical stage in nonseminomatous germ cell tumors. ( 23238629 )
2013
19
Bilateral laparoscopic postchemotherapy retroperitoneal lymph-node dissection in nonseminomatous germ cell tumors--a comparison to template dissection. ( 23516988 )
2013
20
Treatment outcome of patients with extragonadal nonseminomatous germ cell tumors: the Saitama Cancer Center experience. ( 22763659 )
2013
21
Late recurrence of nonseminomatous germ cell tumor successfully treated with intensity-modulated radiation therapy. ( 23868903 )
2013
22
What is the role of enlarged lymph node resection alone in patients with nonseminomatous germ cell tumor who had stage II or III disease? ( 22682983 )
2012
23
Correlation between retroperitoneal lymph node size and presence of metastases in nonseminomatous germ cell tumors. ( 22180527 )
2012
24
Extraperitoneal laparoscopic retroperitoneal lymph node dissection for early-stage testicular nonseminomatous germ cell tumors: initial experience. ( 22524310 )
2012
25
Genomic characterization of testis cancer: association of alterations with outcome of clinical stage 1 mixed germ cell nonseminomatous germ cell tumor of the testis. ( 22503760 )
2012
26
Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumor: a large single institution experience. ( 22177913 )
2012
27
The "growing teratoma syndrome" in primary mediastinal nonseminomatous germ cell tumors: criteria based on current practice. ( 22713299 )
2012
28
Management of residual mass in nonseminomatous germ cell tumors following chemotherapy. ( 21969846 )
2011
29
Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group. ( 21482994 )
2011
30
Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experience. ( 21190791 )
2011
31
Postchemotherapy residual masses in nonseminomatous germ cell tumor patients: 18F-FLT PET is unlikely to identify mature teratoma, but imaging of alphav beta3 integrin expression could. ( 21536932 )
2011
32
Words of wisdom. Re: management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery. ( 21524725 )
2011
33
Gynecomastia as a first clinical sign of nonseminomatous germ cell tumor. ( 21625076 )
2011
34
Paclitaxel+BEP (T-BEP) regimen as induction chemotherapy in poor prognosis patients with nonseminomatous germ cell tumors: a phase II study. ( 21764427 )
2011
35
Stage I nonseminomatous germ cell tumor of the testis: more questions than answers? ( 21570606 )
2011
36
Trends of retroperitoneal lymphadenectomy use in patients with nonseminomatous germ cell tumor of the testis: a population-based study. ( 21509630 )
2011
37
Secondary malignancies among nonseminomatous germ cell tumor cancer survivors. ( 21412759 )
2011
38
Report of the long-term efficacy of two cycles of adjuvant bleomycin/etoposide/cisplatin in patients with stage I testicular nonseminomatous germ-cell tumors (NSGCT): a risk adapted protocol of the Hellenic Cooperative Oncology Group. ( 19362863 )
2011
39
Management of low-stage nonseminomatous germ cell tumors of testis: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009. ( 21986224 )
2011
40
Thoracic metastasectomy for nonseminomatous germ cell tumors. ( 20502259 )
2010
41
Influence of suboptimal treatment in patients with mediastinal primary nonseminomatous germ cell tumors. ( 20185939 )
2010
42
Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery. ( 20026807 )
2010
43
Nonseminomatous germ cell tumor of the testes metastatic to the corpus cavernosum of the penis. ( 19931126 )
2010
44
Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor. ( 20472276 )
2010
45
Clinical relevance of HER-2/neu overexpression in patients with testicular nonseminomatous germ cell tumor. ( 20209452 )
2010
46
Outcome following resection for patients with primary mediastinal nonseminomatous germ-cell tumors and rising serum tumor markers post-chemotherapy. ( 19889611 )
2010
47
Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis. ( 20535294 )
2010
48
Paclitaxel plus ifosfamide followed by high-dose carboplatin plus etoposide for patients with relapsed primary mediastinal nonseminomatous germ cell tumors: benefit from chemotherapy, surgery, or both? ( 21060034 )
2010
49
Management of good-risk metastatic nonseminomatous germ cell tumors of the testis: current concepts and controversies. ( 20535293 )
2010
50
Management options for stage 1 nonseminomatous germ cell tumors of the testis. ( 20535290 )
2010

Variations for Nonseminomatous Germ Cell Tumor

ClinVar genetic disease variations for Nonseminomatous Germ Cell Tumor:

6
# Gene Variation Type Significance SNP ID Assembly Location
1 BRAF NM_004333.4(BRAF): c.1799T> A (p.Val600Glu) single nucleotide variant Pathogenic/Likely pathogenic rs113488022 GRCh37 Chromosome 7, 140453136: 140453136

Expression for Nonseminomatous Germ Cell Tumor

Search GEO for disease gene expression data for Nonseminomatous Germ Cell Tumor.

Pathways for Nonseminomatous Germ Cell Tumor

GO Terms for Nonseminomatous Germ Cell Tumor

Biological processes related to Nonseminomatous Germ Cell Tumor according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cell-cell signaling GO:0007267 8.96 CGB5 CGB7
2 female gamete generation GO:0007292 8.62 CGB5 CGB7

Sources for Nonseminomatous Germ Cell Tumor

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....